Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

Where this comes from

• Record sourced from PubMed, PMID 28301577.
• Also identified by DOI 10.1371/journal.pone.0174493 and PMC identifier 5354437.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.